Munch Mark 4

What Happened

• Mark Munch, Executive Vice President & President of Bruker Nano Inc., exercised 2,000 stock options on Feb 13, 2026 at an exercise price of $22.19 (total cost $44,380) and sold 2,000 common shares in an open-market transaction the same day at $36.94 per share (proceeds $73,880). The Form 4 shows the option exercise (transaction code M) and an immediate sale (transaction code S), which is effectively a cashless exercise.

Key Details

• Transaction dates and prices:
  • 2026-02-13: Exercise (M) — 2,000 shares @ $22.19 (Acquired) = $44,380
  • 2026-02-13: Sale (S) — 2,000 shares @ $36.94 (Disposed) = $73,880
  • 2026-02-13: Derivative disposition (M) — 2,000 @ $0.00 (reflects conversion of the option)
• Shares owned after the transaction: Not specified in the filing.
• Footnotes:
  • F1: Sales were effected pursuant to a Rule 10b5-1 trading plan (pre‑arranged plan).
  • F2: The option grant dates back to Oct 4, 2016 and vested on its anniversaries (vesting schedule noted).
• Filing timeliness: Form filed 2026-02-18 for a 2026-02-13 transaction — filed within the SEC’s Form 4 deadline (timely).

Context

• Because the exercise and sale occurred the same day and the sale was made under a 10b5-1 plan, this appears to be a routine cashless exercise and disposition rather than an isolated open-market decision. The 10b5-1 disclosure indicates the sales were pre‑planned; the vesting footnote shows the options originated in 2016 and were subject to a multi‑year vesting schedule. This is factual reporting of insider activity and does not, by itself, indicate management’s view of the company’s prospects.